Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Neil Solomons currently holds 95,799 shares of Aurinia Pharmaceuticals Inc. (AUPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Neil Solomons has been a net seller of AUPH stock. They have purchased $0 and sold $13.3M worth of shares.
Neil Solomons's most recent insider trade was on Mar 2, 2022, when they sold 8,500 shares at $0.00 per share.
Neil Solomons serves as Executive at Aurinia Pharmaceuticals Inc. (AUPH). They have executed 17 insider transactions totaling $13.3M over their tenure at the company.
Neil Solomons holds the position of Executive at Aurinia Pharmaceuticals Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Neil Solomons has shown a selling trading pattern, with $0 in total purchases and $13.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Neil Solomons was on Sep 10, 2021, when they sold $3.0M worth of AUPH shares. This transaction involved 150,000 shares at $19.84 per share.
Neil Solomons currently owns 95,799 shares of Aurinia Pharmaceuticals Inc. (AUPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Neil Solomons's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Neil Solomons has 17 Form 4 filings on record as an insider at Aurinia Pharmaceuticals Inc..
Set alerts for Neil Solomons and 40,000+ other insiders.